Deutsche Bank Ag\ Adaptimmune Therapeutics PLC Transaction History

Deutsche Bank Ag\

$240 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 13, 2021	SELL	$4.9 - $6.83 $2,616 - $3,647	-534 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$4.0 - $9.2 $2,136 - $4,912	534 New	534 $3,000
Q1 2020 May 14, 2020	SELL	$1.2 - $4.52 $110 - $415	-92 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$0.72 - $1.43 $554 - $1,101	-770 Reduced 89.33%	92 $0
Q3 2019 Nov 14, 2019	SELL	$1.43 - $3.81 $27,976 - $74,538	-19,564 Reduced 95.78%	862 $1,000
Q2 2019 Aug 14, 2019	SELL	$3.23 - $5.41 $896,244 - $1.5 Million	-277,475 Reduced 93.14%	20,426 $81,000
Q1 2019 May 15, 2019	BUY	$3.63 - $6.06 $654,129 - $1.09 Million	180,201 Added 153.1%	297,901 $1.28 Million
Q4 2018 Feb 14, 2019	BUY	$3.76 - $14.16 $406,613 - $1.53 Million	108,142 Added 1131.43%	117,700 $676,000
Q3 2018 Dec 21, 2021	BUY	$8.27 - $13.56 $78,986 - $129,511	9,551 Added 136442.86%	9,558 $130,000
Q3 2018 Nov 14, 2018	SELL	$8.27 - $13.56 $1.09 Million - $1.79 Million	-131,686 Reduced 99.99%	7 $0
Q2 2018 Apr 21, 2020	BUY	$10.42 - $13.74 $88,351 - $116,501	8,479 Added 6.88%	131,693 $1.56 Million
Q2 2018 Aug 14, 2018	SELL	$10.42 - $13.74 $2.22 Million - $2.92 Million	-212,672 Reduced 63.32%	123,214 $1.46 Million
Q1 2018 Oct 18, 2019	BUY	$7.1 - $11.56 $55,869 - $90,965	7,869 Added 2.4%	335,886 $3.77 Million
Q1 2018 May 15, 2018	BUY	$7.1 - $11.56 $1.09 Million - $1.77 Million	153,071 Added 87.5%	328,017 $3.68 Million
Q4 2017 Feb 14, 2018	SELL	$6.68 - $8.74 $775,467 - $1.01 Million	-116,088 Reduced 39.89%	174,946 $1.17 Million
Q3 2017 Nov 14, 2017	BUY	$4.93 - $8.93 $1.43 Million - $2.6 Million	291,034	291,034 $2.38 Million

Others Institutions Holding ADAP

# of Institutions

Shares Held

150M

Call Options Held

60.8K

Put Options Held

5.8K

Matrix Capital Management Company, LP Waltham, MA

37.7M
Shares

$27.1 Million
1.71% of portfolio
Eco R1 Capital, LLC San Francisco, CA

27.4M
Shares

$19.7 Million
1.13% of portfolio
Nea Management Company, LLC Timonium, MD

17.1M
Shares

$12.3 Million
1.24% of portfolio
Baillie Gifford & CO

16.8M
Shares

$12.1 Million
0.01% of portfolio
Long Focus Capital Management, LLC San Juan, PR

13.3M
Shares

$9.58 Million
0.46% of portfolio

View Full List

About Adaptimmune Therapeutics PLC

Ticker ADAP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 163,370,000
Market Cap $118M
Description
Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, focuses on providing novel cell therapies primarily to patients with solid tumors in the United States and the United Kingdom. The company's specific peptide enhanced affinity receptor (SPEAR) T-cell platform enables it to identify cancer targets. It is developing ADP-A2M4...

More about ADAP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account